Form 6-K AURORA CANNABIS INC For: May 20
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Aurora Cannabis (ACB:CN) (ACB) PT Raised to Cdn$27 at Cantor Fitzgerald; Positive on Reliva Deal
May 21, 2020 8:18 AM EDTCantor Fitzgerald analyst Pablo Zuanic raised the price target on Aurora Cannabis (ACB:CN) (NYSE: ACB) to Cdn$27.00 (from Cdn$22.00) while maintaining an Overweight rating after the company agreed to acquire Reliva.
The analyst commented, "ACB proved last Thursday (5/14) that it is making great strides with its reset (divestitures, cost cuts, cash flow improvement), and played down the risk of further dilution. Over the past 90 days into the print, the stock had been... More
